Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)

NCT02270099 is registered in ClinicalTrials.gov with Hologic, Inc. as lead sponsor.

NCT NCT02270099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02270099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Lead sponsor
Hologic, Inc.
Phase
Observational
Overall status
Completed
Start date
December 31, 2014
Completion date
June 30, 2017
Enrollment
839 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

herpes simplex infections